| SC 13D/A | 2024-03-19 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 30,000,000 | 11.6% | EDGAR |
| SC 13G | 2024-03-01 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 19,221,743 | 6.9% | EDGAR |
| SC 13G/A | 2024-02-14 | Point72 Asset Management, L.P. | IOVANCE BIOTHERAPEUTICS, INC. | 0 | 0.0% | EDGAR |
| SC 13G/A | 2024-02-14 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 11,979,415 | 4.7% | EDGAR |
| SC 13G/A | 2024-02-13 | VANGUARD GROUP INC | IOVANCE BIOTHERAPEUTICS, INC. | 22,812,820 | 8.9% | EDGAR |
| SC 13G/A | 2024-02-09 | MHR FUND MANAGEMENT LLC | IOVANCE BIOTHERAPEUTICS, INC. | 17,605,902 | 6.9% | EDGAR |
| SC 13G/A | 2024-01-26 | BlackRock Inc. | IOVANCE BIOTHERAPEUTICS, INC. | 19,071,756 | 7.5% | EDGAR |
| SC 13G/A | 2024-01-25 | STATE STREET CORP | IOVANCE BIOTHERAPEUTICS, INC. | - | 6.4% | EDGAR |
| SC 13D/A | 2023-10-27 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 25,000,000 | 15.8% | EDGAR |
| SC 13G | 2023-02-17 | Point72 Asset Management, L.P. | IOVANCE BIOTHERAPEUTICS, INC. | 7,347,600 | 4.6% | EDGAR |
| SC 13G/A | 2023-02-14 | Avoro Capital Advisors LLC | IOVANCE BIOTHERAPEUTICS, INC. | 7,020,000 | 4.4% | EDGAR |
| SC 13G/A | 2023-02-14 | PERCEPTIVE ADVISORS LLC | IOVANCE BIOTHERAPEUTICS, INC. | 9,971,780 | 6.3% | EDGAR |
| SC 13G/A | 2023-02-09 | VANGUARD GROUP INC | IOVANCE BIOTHERAPEUTICS, INC. | 14,463,082 | 9.2% | EDGAR |
| SC 13G/A | 2023-02-06 | WELLINGTON MANAGEMENT GROUP LLP | IOVANCE BIOTHERAPEUTICS, INC. | 421,610 | 0.3% | EDGAR |
| SC 13G | 2023-02-03 | BlackRock Inc. | IOVANCE BIOTHERAPEUTICS, INC. | 12,076,276 | 7.7% | EDGAR |
| SC 13G | 2023-02-02 | STATE STREET CORP | IOVANCE BIOTHERAPEUTICS, INC. | - | 9.3% | EDGAR |
| SC 13D/A | 2023-01-13 | Quogue Capital LLC | IOVANCE BIOTHERAPEUTICS, INC. | 20,000,000 | 12.5% | EDGAR |
| SC 13G | 2022-12-30 | MHR FUND MANAGEMENT LLC | IOVANCE BIOTHERAPEUTICS, INC. | 10,511,920 | 5.8% | EDGAR |
| SC 13G/A | 2022-02-24 | BlackRock Inc. | IOVANCE BIOTHERAPEUTICS, INC. | 7,408,505 | 4.7% | EDGAR |
| SC 13G/A | 2022-02-14 | PRICE T ROWE ASSOCIATES INC /MD/ | IOVANCE BIOTHERAPEUTICS, INC. | 4,663,785 | 2.9% | EDGAR |